A long-term, open-label trial of the safety and efficacy of etanercept (25 mg twice weekly) in patients with rheumatoid arthritis (interim analysis of 4-year data)

Saved in:
Bibliographic Details
Main Authors: Klareskog, L, Wajdula, J, Pedersen, R
Format: Conference Proceeding
Language:English
Subjects:
Medicin och hälsovetenskap
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0003-4967